Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Vascular Solutions floats at second attempt:

This article was originally published in Clinica

Executive Summary

Vascular Solutions has raised $42 million in its initial public offering, its second attempt at flotation. Vascular recently received US FDA approval for its arterial puncture closure device, Duett, and has been named in a patent lawsuit with St Jude Medical, which manufactures under licence the Angio-Seal haemostasis puncture closure device (see Clinica No 917, p 1). The Minneapolis, Minnesota-based company postponed an offering in October 1999, citing the turbulent condition of the stock market.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT076745

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel